Table 2.
Change in clinical characteristics (baseline to post-trial)
| Change in clinical characteristics | Control |
Intervention |
||
|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | |
| Change in glycated hemoglobin (%)* | 12 | +0.03 (0.24) | 11 | −0.18 (0.20)† |
| No weight loss | 7 | +0.10 (0.21) | 5 | −0.14 (0.27) |
| Some weight loss | 5 | −0.06 (0.30) | 6 | −0.22 (0.13) |
| Change in BMI | 12 | −0.03 (0.49) | 11 | −0.11 (0.41) |
| Change in weight (in kg) | 12 | −0.09 (1.23) | 11 | −0.26 (1.02) |
*p<0.05 for change in clinical characteristic between intervention and control group.
†p<0.05 for change in clinical characteristic within the intervention or control group.
BMI, body mass index.